Leveraging our core competencies in NGS, bioinformatics and liquid biopsy, Genecast Biotechnology provides individualized precision diagnosis and companion diagnosis for cancer
To explore how Genecast influences cancer patients' lives.
Strengths of Genecast Biotechnology
Next Generation Sequencing (NGS) technology for detection of genetic alterations in circulating tumor DNA (ctDNA) with advantages in high sensitivity, specificity and high throughputs , is widely used in tumor profiling, relapse detection and drug efficacy monitoring.
Orientation of scientific research
Coming from Clinical, to Clinical
In close partnership with clinicians, our research is clinically oriented. We actively collaborate with clinical research institutions to promote translational research, thus help doctors discover and solve clinical problems.
We have established a scientific research network with the key cancer hospitals around the country and carried out almost 100 research collaboration projects. In addition, we are collaborating with multiple international biotech/pharma companies in drug discovery and development programs.
Achievements in scientific research
Emergence on the International Stage
At the 53th ASCO and the 18th WCLC , we presented and shared our latest achievements in translational research in cancer research with oncologists and researchers around the world
News2019-05-28 ASCO 2019 | 24 Research Projects from Genecast Selected 2019-04-19 HalioDx Signs an Exclusive Agreement with Genecast to Make Immunoscore® Available in China 2018-10-19 Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China